Nephros Inc (NEPH) stock

NEPHNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 13/3020% below fair value

$3.31+0.24 (+7.82%)

Close on Nov 12, 2026Market cap $35.95MP/E 18.4Yield –

Earnings

Nephros's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report

–

Not yet scheduled

Revenue, Q3 FY2026

$5.60M

EPS, Q3 FY2026

$0.05

Latest guidance

Reaffirmed

Feb 23, 2022 · 1 item

Quarterly results

Revenue and earnings per share from each of Nephros's earnings releases, newest first

Quarter	Reported	Revenue	YoY	EPS	Source
Q3 FY2026ended Sep 30, 2026	Nov 5, 2026after the close	$5.60M	–	$0.05	Release
Q2 FY2026ended Jun 30, 2026	Aug 6, 2026after the close	$6.00M	+36.4%	$0.11	Release
Q1 FY2026ended Mar 31, 2026	May 7, 2026after the close	$5.21M	+6.4%	$0.01	Release
Q2 FY2025ended Jun 30, 2025	Aug 11, 2025after the close	$4.40M	–	$0.02	Release
Q1 FY2025ended Mar 31, 2025	May 8, 2025after the close	$4.90M	–	$0.05	Release
Q4 FY2024ended Dec 31, 2024	Mar 6, 2025after the close	$3.90M	+18.2%	$0.03	Release
Q3 FY2024ended Sep 30, 2024	Nov 13, 2024after the close	$3.50M	–	$0.02	Release
Q1 FY2024ended Mar 31, 2024	May 9, 2024after the close	–	–	–	Release
Q4 FY2023ended Dec 31, 2023	Mar 7, 2024after the close	$3.30M	+26.9%	–	Release
Q2 FY2023ended Jun 30, 2023	Aug 9, 2023after the close	$3.50M	+20.7%	-$0.04	Release
Q1 FY2023ended Mar 31, 2023	Apr 4, 2023after the close	$3.70M	+68.2%	–	Release
Q4 FY2022ended Dec 31, 2022	Mar 8, 2023after the close	$2.60M	-7.1%	–	Release
Q3 FY2022ended Sep 30, 2022	Oct 11, 2022before the open	$2.50M	-3.8%	–	Release
Q2 FY2022ended Jun 30, 2022	Jul 6, 2022before the open	$2.90M	–	–	Release
Q1 FY2022ended Mar 31, 2022	May 4, 2022after the close	$2.20M	–	-$0.20	Release
Q4 FY2021ended Dec 31, 2021	Feb 23, 2022after the close	$2.80M	–	–	Release
Q3 FY2021ended Sep 30, 2021	Oct 8, 2021before the open	$2.60M	–	–	Release
Q2 FY2021ended Jun 30, 2021	Jul 8, 2021before the open	–	–	–	Filing
Q1 FY2021ended Mar 31, 2021	Apr 5, 2021before the open	–	–	–	Filing
Q4 FY2020ended Dec 31, 2020	Mar 1, 2021after the close	–	–	–	Filing
Q3 FY2020ended Sep 30, 2020	Oct 6, 2020before the open	–	–	–	Filing
Q2 FY2020ended Jun 30, 2020	Jul 8, 2020before the open	–	–	–	Filing
Q1 FY2020ended Mar 31, 2020	Apr 2, 2020before the open	–	–	–	Filing
Q4 FY2019ended Dec 31, 2019	Feb 27, 2020after the close	–	–	–	Filing
Q3 FY2019ended Sep 30, 2019	Oct 7, 2019after the close	–	–	–	Filing
Q2 FY2019ended Jun 30, 2019	Jul 9, 2019after the close	–	–	–	Filing

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Current guidance

No open guidance: every period Nephros guided for has been reported

Guidance history

Every forecast Nephros put in an earnings release, newest first

Given	Metric	Period	Guidance	Change
Feb 23, 2022	Annual Revenue	FY2022	$13.00M – $13.50M	Reaffirmed
Jan 13, 2022	revenue	FY2022	$13.00M – $13.50M	New

Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.